Turnstone Communications

We are a specialized consultancy agency providing communications, marketing and strategic support to companies and organizations in the life sciences industry. We share client articles on BioVox providing insight into new and established players in the Belgian ecosystem, from innovations and research breakthroughs through to finance and industry trends.

miDiagnostics welcomes Nicolas De Clercq as its new Chief Financial Officer

Leuven, Belgium, 30 March 2022 – miDiagnostics, a fast-growing POC diagnostics company backed by Belgian Family Offices, announces today that Nicolas De […] March 30, 2022 · Turnstone Communications

Rejuvenate Biomed Started a Groundbreaking Clinical Trial and Expands for Future Growth

• Started clinical trial with lead candidate RJx-01 for treating sarcopenia • Expands the team and moved to new offices and lab Diepenbeek, […] March 29, 2022 · Turnstone Communications

New incubator biotope by VIB launches to support biotech startup teams on their journey to success

Ghent, Belgium, 24 March 2022 – Incubator program biotope by VIB launches today to support biotech startup teams looking to impact people’s lives through […] March 24, 2022 · Turnstone Communications

Qbic announces first close of new fund at EUR 49 million to invest in spin-offs from world-class knowledge partners

St-Denijs-Westrem, Belgium, 17 March 2022 – Qbic, an inter-university venture capital fund focusing on the transformation of technological breakthroughs into […] March 17, 2022 · Turnstone Communications

flanders.healthTech launches 14 unique innovation projects in healthcare

Ghent, Belgium, 10 March 2022 – Following the launch of the cluster flanders.healthTech in 2021, the first round of 14 […] March 10, 2022 · Turnstone Communications

miDiagnostics ultra-fast COVID-19 PCR Test succeeds in Brussels Airport pilot study

Leuven, Belgium, 17 February 2022 – miDiagnostics, a fast-growing POC diagnostics company backed by Belgian Family Offices, announces the success of the […] February 17, 2022 · Turnstone Communications

Newton Biocapital launches a new fund with initial capital commitments of EUR 50 million and target size of EUR 150 million

Brussels, Belgium, 15 February 2022 – Newton Biocapital (“Newton”), a life sciences investor, announces the launch of its new fund […] February 15, 2022 · Turnstone Communications

ElmediX raises nearly 12 million euros to develop innovative heat technology to fight cancer

Mechelen, Belgium, January 25, 2022 – Belgian company ElmediX is developing intensive and controlled heat treatments for the treatment of […] January 25, 2022 · Turnstone Communications

New start-up Trince raises EUR 4 million for innovative technology to produce personalized cancer therapies safer, cheaper, and faster

Ghent, Belgium, 6 December 2021 – Trince, a spin-off of Ghent University (UGent), is developing innovative and efficient technology to insert […] December 6, 2021 · Turnstone Communications

Rejuvenate Biomed: Expanding peoples’ health spans by boosting cell resilience

Aging will affect each and every one of us at some point; it is part of the covenant of life. […] November 24, 2021 · Turnstone Communications

Belgium has all the ingredients to be a top country for data science in health – but we have to act now!

– Science for health will connect decisionmakers with researchers, clinicians, and company leaders on the topic of data science in healthcare – The event […] November 15, 2021 · Turnstone Communications

Rejuvenate Biomed raises a EUR 15.7 million Series B to accelerate clinical development of its sarcopenia treatment for healthy aging

Heusden-Zolder, Belgium, Schlieren, Zürich, Switzerland, and Luxembourg, Grand Duchy of Luxembourg, 12 October 2021 – Rejuvenate Biomed NV (‘Rejuvenate’), a […] October 12, 2021 · Turnstone Communications

EsoBiotec ready to transform cell therapy cancer treatments

– EsoBiotec, a recently founded biotech company, announces a EUR 6 million pre-series A round comprised of non-dilutive funding from […] September 30, 2021 · Turnstone Communications

A vision of the future: smart contact lenses to treat patients with iris disorders and light sensitivity

A woman opens her front door and looks to the sky to judge the weather. It’s sunny and inside her […] September 22, 2021 · Turnstone Communications

Newton Biocapital invests in PRISM BioLab to support development of a unique peptide mimetic technology platform to discover new drugs for intractable diseases

Brussels, Belgium / Tokyo, Japan – 9 September 2021 – Newton Biocapital (“Newton”), a life sciences investment fund active in […] September 9, 2021 · Turnstone Communications